These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 301877)

  • 1. Relationship of sialic acid to function and in vivo survival of human factor VIII/von Willebrand factor protein.
    Sodetz JM; Pizzo SV; McKee PA
    J Biol Chem; 1977 Aug; 252(15):5538-46. PubMed ID: 301877
    [No Abstract]   [Full Text] [Related]  

  • 2. Carbohydrate on human factor VIII/von Willebrand factor. Impairment of function by removal of specific galactose residues.
    Sodetz JM; Paulson JC; Pizzo SV; McKee PA
    J Biol Chem; 1978 Oct; 253(20):7202-6. PubMed ID: 100492
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor VIII/von Willebrand factor protein. Galactose a cryptic determinant of von Willebrand factor activity.
    Gralnick HR
    J Clin Invest; 1978 Aug; 62(2):496-9. PubMed ID: 307560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor VIII/von Willebrand protein. Modification of its carbohydrate causes reduced binding to platelets.
    Kao KJ; Pizzo SV; McKee PA
    J Biol Chem; 1980 Nov; 255(21):10134-9. PubMed ID: 6776109
    [No Abstract]   [Full Text] [Related]  

  • 5. von Willebrand factor: characterization of interaction among von Willebrand factor, ristocetin and platelet.
    Hashimoto S; Suzuki K
    Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):851-63. PubMed ID: 317771
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhibitory effect of ristocetin and factor VIII/von Willebrand factor protein on human platelet adenylate cyclase activity.
    Kao KJ; Tsai BS; McKee PA; Lefkowitz RJ; Pizzo SV
    Thromb Res; 1983 May; 30(3):301-8. PubMed ID: 6408756
    [No Abstract]   [Full Text] [Related]  

  • 7. von Willebrand Factor/Factor VIII adsorption to surfaces from human plasma.
    Horbett TA; Counts RB
    Thromb Res; 1984 Dec; 36(6):599-608. PubMed ID: 6442015
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of von Willebrand factor: effects of different kinds of carbohydrate oxidases, SH-inhibitors and some other chemical reagents.
    Fukui H; Mikami S; Okuda T; Murashima N; Takase T
    Br J Haematol; 1977 Jun; 36(2):259-70. PubMed ID: 301402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adhesive properties of the carbohydrate-modified von Willebrand factor (CHO-vWF).
    Federici AB; De Romeuf C; De Groot PG; Samor B; Lombardi R; D'Alessio P; Mazurier C; Mannucci PM; Sixma JJ
    Blood; 1988 Apr; 71(4):947-52. PubMed ID: 3128350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
    Weinstein MJ; Chute LE
    J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of inhibition by trinitrophenylation of the ristocetin cofactor activity of von Willebrand factor.
    Santoro SA; Cowan JF
    Biochim Biophys Acta; 1984 Feb; 797(2):178-85. PubMed ID: 6607747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet receptors for human Factor VIII/von Willebrand protein: functional correlation of receptor occupancy and ristocetin-induced platelet aggregation.
    Kao KJ; Pizzo SV; McKee PA
    Proc Natl Acad Sci U S A; 1979 Oct; 76(10):5317-20. PubMed ID: 315561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Obesity, haemostasis and the fibrinolytic system.
    Mertens I; Van Gaal LF
    Obes Rev; 2002 May; 3(2):85-101. PubMed ID: 12120424
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pseudo-von Willebrand's disease. An intrinsic platelet defect with aggregation by unmodified human factor VIII/von Willebrand factor and enhanced adsorption of its high-molecular-weight multimers.
    Weiss HJ; Meyer D; Rabinowitz R; Pietu G; Girma JP; Vicic WJ; Rogers J
    N Engl J Med; 1982 Feb; 306(6):326-33. PubMed ID: 6798442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. von Willebrand factor binds to platelets and induces aggregation in platelet-type but not type IIB von Willebrand disease.
    Miller JL; Kupinski JM; Castella A; Ruggeri ZM
    J Clin Invest; 1983 Nov; 72(5):1532-42. PubMed ID: 6415113
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure - function relationship of factor VIII/von Willebrand factor. Application to the study of variant von Willebrand's disease and cryosupernatant prepared from normal plasma.
    Pietu G; Obert B; Larrieu MJ; Meyer D
    Thromb Res; 1980 Aug 15-Sep 1; 19(4-5):671-85. PubMed ID: 6777898
    [No Abstract]   [Full Text] [Related]  

  • 17. Dispersity of human factor VIII--Von Willebrand factor.
    van Mourik JA; Bolhuis PA
    Thromb Res; 1978 Jul; 13(1):15-24. PubMed ID: 308712
    [No Abstract]   [Full Text] [Related]  

  • 18. Molecular biology of factor VIII/von Willebrand Factor.
    Meyer D; McKee PA; Hoyer LW; Zimmerman TS; Gralnick HR
    Thromb Haemost; 1978 Oct; 40(2):245-51. PubMed ID: 310584
    [No Abstract]   [Full Text] [Related]  

  • 19. Von Willebrand factor, diabetes mellitus and retinopathy.
    Paton RC; Passa P; Canivet J
    Horm Metab Res Suppl; 1981; 11():55-8. PubMed ID: 6797913
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The factor VIII complex: structure and function.
    Hoyer LW
    Prog Clin Biol Res; 1981; 72():1-26. PubMed ID: 6801681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.